Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0908 per EA under NDC 33342019407. Its NADAC has been published 279 times since Jan 15, 2020.
Strength
37.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342019407
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204889On Market Since
10/6/2017
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 279 times since Jan 15, 2020, and over the history we have for it it has declined 40.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0908 per EA |
|---|---|
| All-time high | $0.1530 (Jan 15, 2020) |
| All-time low | $0.0712 (Nov 20, 2024) |
| Median price | $0.1049 |
| Average price | $0.1093 |
| Largest weekly change | +28.7% (Aug 21, 2024) |
| Weeks tracked | 279 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Macleods Pharmaceuticals Limited, is $0.0908 per EA (NDC 33342019407), effective May 14, 2025.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 40.7%. It has been tracked across 279 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Jan 15, 2020, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.1530 (Jan 15, 2020), with a median of $0.1049 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 37.5 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 33342019407) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification